{"product_id":"penn-medicine-penn-neuromuscular-symposium-2026","title":"Penn Medicine Penn Neuromuscular Symposium 2026","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: neurologists and neuromuscular specialists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e1. Overview\u003c\/p\u003e\n\u003cp\u003eThe annual Penn Neuromuscular Symposium is designed to provide clinicians with a comprehensive and practical update on the diagnosis and management of neuromuscular disorders. Through expert-led presentations and case-based discussions, attendees will learn how to approach a wide spectrum of neuromuscular diseases, interpret diagnostic studies, and apply current best practices in patient care. The course will also highlight recent advances in the field, including newly approved therapies and emerging innovations that are shaping the future of neuromuscular medicine.\u003c\/p\u003e\n\u003cp\u003e2. Learning Objectives\u003c\/p\u003e\n\u003ch3\u003eAfter completing this activity, participants should be able to:\u003c\/h3\u003e\n\u003cp\u003eDescribe novel treatments for myasthenia gravis, including emerging therapies and their mechanisms of action.\u003c\/p\u003e\n\u003cp\u003eDiscuss new diagnostic approaches and treatment strategies for neuropathy associated with amyloidosis.\u003c\/p\u003e\n\u003cp\u003eDiscuss the different types of demyelinating neuropathies and outline current approaches to their diagnosis and management.\u003c\/p\u003e\n\u003cp\u003eDescribe novel treatments for spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS), including recently approved therapies and emerging clinical trial data.\u003c\/p\u003e\n\u003cp\u003eDescribe current approaches to the diagnosis and treatment of pulmonary complications in neuromuscular diseases.\u003c\/p\u003e\n\u003cp\u003eApply antibody testing in the diagnosis of inflammatory myopathies and describe novel therapies under investigation for their treatment.\u003c\/p\u003e\n\u003cp\u003eDiscuss the role and recent advances of gene therapy in the treatment of hereditary myopathies.\u003c\/p\u003e\n\u003cp\u003eDiscuss challenging clinical cases to enhance diagnostic reasoning and management strategies in neuromuscular disorders.\u003c\/p\u003e\n\u003cp\u003eDiscuss recent advances in the diagnosis and treatment of hereditary neuropathies.\u003c\/p\u003e\n\u003cp\u003e3. Target Audience\u003c\/p\u003e\n\u003cp\u003eBest for neurologists and neuromuscular specialists who want updates on gene therapies, myasthenia gravis treatments, and neuropathies.\u003c\/p\u003e\n\u003cp\u003e4. Topics\u003c\/p\u003e\n\u003cp\u003eAdvances in Gene- and RNA-Targeted Therapies for SMA and ALS\u003c\/p\u003e\n\u003cp\u003eAntibody Testing and Novel Therapies in Inflammatory Myopathies\u003c\/p\u003e\n\u003cp\u003eDiagnosing and Managing Demyelinating Neuropathies\u003c\/p\u003e\n\u003cp\u003eHereditary Neuropathies, Including hATTR – New Insights and Treatments\u003c\/p\u003e\n\u003cp\u003eHow to Incorporate Novel Treatments in Myasthenia Gravis\u003c\/p\u003e\n\u003cp\u003eNeuromuscular Case Presentation – 01\u003c\/p\u003e\n\u003cp\u003eNeuromuscular Case Presentation\u003c\/p\u003e\n\u003cp\u003eWelcome\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405749440708,"sku":null,"price":26.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/Penn-Medicine-Penn-Neuromuscular-Symposium-2026.jpg?v=1784215595","url":"https:\/\/medicalcoursespro.com\/products\/penn-medicine-penn-neuromuscular-symposium-2026","provider":"Medicalcoursespro","version":"1.0","type":"link"}